Your session is about to expire
← Back to Search
Exercise Guidelines for Spinal Cord Injury
N/A
Waitlist Available
Led By Kathleen Martin Ginis, PhD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
(iv) reporting chronic pain, defined as pain that persists or recurs for more than 3 mos on a question taken from the US Model SCI Systems measures: ["Using a 0 to 10 scale with 10 being pain so severe you could not stand it and 0 being no pain, what has been the usual level of pain over the past 3 months?"] and scoring at or above 1;
(i) adults aged >18 with an spinal cord injury (SCI), traumatic or non-traumatic cause;
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 months, 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will test whether home-/community-based exercise, prescribed according to new SCI exercise guidelines and supported through a theory-based behavioural intervention, can significantly reduce chronic pain in adults with SCI.
Who is the study for?
Adults over 18 with spinal cord injury (SCI), experiencing chronic pain for more than 3 months, and doing less than the recommended levels of exercise can join. They must be able to perform a maximal exercise test and have access to a phone. Those with recent injuries (<12 months) or medical conditions that make exercising unsafe cannot participate.
What is being tested?
The trial is testing if following new SCI exercise guidelines in a home/community setting can significantly reduce chronic pain in adults with SCI. Participants will either follow these exercise recommendations or be part of a control group, to see which method is more effective at managing pain.
What are the potential side effects?
While not explicitly stated, potential side effects from increased physical activity may include muscle soreness, fatigue, and an initial increase in pain symptoms as the body adjusts to the new exercise regimen.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been experiencing pain for more than 3 months.
Select...
I am over 18 and have a spinal cord injury.
Select...
My spinal cord injury is classified between A-D and is at level C3 or lower.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 3 months, 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 months, 6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change from Baseline, between and within group comparison, in Bodily Pain
Secondary study objectives
Capability Wellbeing
Economic Evaluation: Health Care Costs
Fasting plasma concentrations of cytokines IL-6
+14 moreOther study objectives
Fidelity of the fitness trainer and exercise counselor to their protocols
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Exercise ConditionExperimental Treatment1 Intervention
The intervention is a personalized exercise prescription based on the International Scientific Spinal Cord Injury (SCI) Exercise Guidelines. Participants begin at the Starting Level guideline: 20 min aerobic exercise, 2x/wk, at 70% of heart rate reserve (or a Borg Continuous Ratio 0-10 rating of 6), \& 3 sets of 10 repetitions of strengthening exercises (each major functioning muscle group at 50-80% of 1-rep max), 2x/wk. Participants will gradually increase aerobic exercise to 30 min, 3x/wk (i.e. the Advanced Level guideline). Exercise implementation will be supported by a fitness trainer and an exercise counsellor with SCI-specific training and experience.
Group II: Wait-list ControlActive Control1 Intervention
Control participants will not get an exercise prescription. They will be asked to refrain from lifestyle changes for 6 mos. After the 6-month waitlist period, Controls will receive the same resources as Exercisers.
Find a Location
Who is running the clinical trial?
University of British ColumbiaLead Sponsor
1,472 Previous Clinical Trials
2,489,570 Total Patients Enrolled
Kathleen Martin Ginis, PhDPrincipal InvestigatorUniversity of British Columbia
3 Previous Clinical Trials
76 Total Patients Enrolled